Mahamaya Lifesciences IPO is scheduled to list on 18 Nov 2025 on NSE, BSE.
Listed
SME IPO
MAHALIFE
Mahamaya Lifesciences IPO Listing Price Today
Mahamaya Lifesciences IPO listed on 18 Nov 2025 at ₹116 against an issue price of ₹114, a listing gain of +1.75%.
- Issue price
- ₹114
- Actual listing price
- ₹116
- Listing Date
- 18 Nov 2025
- Exchange
- NSE, BSE
Live share price
Mahamaya Lifesciences share price
-
vs issue price
Open-
Day high-
Day low-
Exchange-
Loading live price…
The live price isn't available right now. Check back shortly.
Source: Yahoo Finance. Prices may be delayed by a few minutes.
GMP vs actual
Mahamaya Lifesciences listing price vs GMP estimate
| Issue price | ₹114 |
|---|---|
| Latest GMP | ₹2 (+1.75%) |
| Expected listing price (issue price + GMP) | ₹116 |
| Actual listing price | ₹116 |
| Listing gain | +1.75% |
| Difference from GMP estimate | +₹0 (+0.00%) |
GMP is an unofficial grey market indicator, not a guarantee of the listing price.
Empirical GMP Accuracy:
Across 117 Indian IPOs, positive GMP predicted positive listing gains 69.8% of the time (35.6% of SME IPOs opened within 10% of their GMP estimate).
View Research Report →
Listing day
Listing day timings
| Listing Date | 18 Nov 2025 |
|---|---|
| Special pre-open session | 9:00 AM - 9:45 AM |
| Normal trading starts | 10:00 AM |
| Exchange | NSE, BSE |
FAQ
Mahamaya Lifesciences IPO: frequently asked questions
Mahamaya Lifesciences IPO listed at ₹116 against an issue price of ₹114, a listing gain of +1.75%.
On listing day, a special pre-open session runs from 9:00 AM to 9:45 AM to set the listing price. Mahamaya Lifesciences shares then start normal trading at 10:00 AM.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.